Kiron Moy Das, M.D., Ph.D., F.R.C.P. A.G.A.F., F.A.C.G.
Chief, Division of Gastroenterology & Hepatology
Professor of Medicine; Biochemistry and Molecular Biology;
Founding Director, Crohn's & Colitis Center of NJ
Rutgers, Robert Wood Johnson Medical School
Dr. Kiron Das has served as Chief of Gastroenterology and Hepatology Departments, RWJ University Medical School and Hospital, Rutgers, New Brunswick, NJ since 1987. He is Professor of Medicine, Biochemistry and Molecular Biology, Rutgers, Robert Wood Johnson Medical School (formerly UMDNJ-Robert Wood Johnson Medical School). He is also Founding Director, Crohn's & Colitis Center of NJ. He keeps providing his services to prestigious national organizations such as NIH, NIDKK, NCI, etc., as advisors and board members.
Dr. Das received his M.D. from the Calcutta University with distinction and his M.R.C.P. as well as Ph.D. from the Royal College Of Physicians (U.K.), University Edinburgh, Scotland. He was awarded Fellowships such as F.R.C.P., F.A.C G., F.A.C.P. and A.G.A.F.
Dr. Das has authored more than 161 peer reviewed research articles along with book chapters and monographs. Dr. Das has been selected as Principal Investigators since 1988 to date with numerous significant research grant support from renowned institutions, foundations, associations and organizations. He is reviewer of prestigious journals like , Gastroenterology, American Journal of Gastroenterology, Journal of Clinical Gastroenterology, Journal of Laboratory and Clinical Investigation, Journal of Pharmacology and Therapeutics, World Journal of Gastroenterology to name a few.
Dr. Das has received numerous honors and awards including Lifetime achievement Award from the AGA (American Gastroenterological Association) Foundation, 2007 Mentors Research Scholar Award, Governor, NJ Chapter, American College of Gastroenterology, elected by the members for the state of New Jersey., “Excellence in Teaching Award from the Foundation of UMDNJ, Best Research Mentorship” - awarded by the Internal Medicine Residents, UMDNJ-Robert Wood Johnson Medical School.
Ashis Mukherjee, M.D., F.A.C.C., F.S.C.A.I.
Associate Program Director
Assistant Clinical Professor of Medicine,
School of Medicine, University of California, Riverside, CA
Dr. Ashis Mukherjee received his Bachelor degree in Electrical Engineering from City College of New York, NY City, N.Y. He earned his M.D. Degree and conducted his residency at the Cornell University Medical College. Dr. Mukherjee completed his fellowships in cardiology and interventional cardiology at the George Washington University Hospital, Washington DC.
Dr. Mukherjee is Interventional Cardiologist with Specialty Interest in Endovascular and Peripheral Vascular Interventions and Structural Heart Disease. He is very active in clinical research areas. Prof. Mukherjee is an Assistant Clinical Professor of Medicine and an Associate Program Director of the Internal Medicine Residency Program University of California Riverside – School of Medicine.
Dr. Mukherjee is one of the top invasive cardiologists in Inland Southern California and is affiliated with multiple hospitals in the Inland Empire area, including Riverside Community Hospital and St. Bernardine Medical Center. He has served as the director of the Inland Empire Heart & Vascular Institute since 2007 and very active in Medical Education including Symposia, Seminars and Grand Rounds.
Dr. Mukherjee has authored numerous research articles, monographs and book chapters including Kochar's Clinical Medicine, 6th Edition, 2015.
Dr. Mukherjee is board certified specialists in Endovascular Medicine, Interventional Cardiology and Cardiovascular Disease by the respective authorized boards. He is a fellow of American College of Cardiology since 1991.
Dr. Mukherjee received academic honors such as Jocelyn Beard Moran Memorial Fellowship in 1990 from American Heart Association and the Alfred Moritz Michel’s Distinguished Award for Efficiency in Medicine in 1988 from Cornell University Medical College.
Debabrata Banerjee, Ph.D.
Associate Professor, Department of Pharmacology
Robert Wood Johnson Medical School
Director, MBS & MCTS Programs
Assistant Dean, Global Initiatives, School of Graduate Studies
Rutgers University, Piscataway, NJ 08854
Debabrata (Debu) Banerjee is an Associate Professor in the Department of Pharmacology at the Rutgers Robert Wood Johnson Medical School, USA, and Assistant Dean for Global Initiatives at the School of Graduate Studies, Rutgers University. He received his BS Chem. from St Xavier’s College, India, PhD in Biochemistry from the University of Calcutta, India, and completed his Postdoctoral training in the Department of Biology at McGill University, Canada between 1983 and 1987. He worked at Memorial Sloan Kettering Cancer Center before joining Rutgers University in 2002. In addition to his role as the Assistant Dean of Global Initiatives and directing two masters programs at SGS, he continues his research on tumor stroma interaction. He is particularly well known for his contribution to our understanding of the origin and function of carcinoma associated fibroblasts in cancer.
Debu has published extensively, contributing over 100 peer reviewed journal articles and book chapters as well as presenting at numerous national and international conferences to date. He has also been awarded 5 patents. He serves on Editorial Boards of the Journal of Chemotherapy, World J Stem Cells and Current Signal Transduction Therapy, and has been a member of the American Association for Cancer Research since 1990. He reviews grant applications for many national funding agencies. He is an honorary visiting Professor at Amity University, India and at Universitas Padjadjaran, Bandung, Indonesia.Debu has published extensively, contributing over 100 peer reviewed journal articles and book chapters as well as presenting at numerous national and international conferences to date. He has also been awarded 5 patents. He serves on Editorial Boards of the Journal of Chemotherapy, World J Stem Cells and Current Signal Transduction Therapy, and has been a member of the American Association for Cancer Research since 1990. He reviews grant applications for many national funding agencies. He is an honorary visiting Professor at Amity University, India and at Universitas Padjadjaran, Bandung, Indonesia.
Indrani Dhar, M.S., RD, CDE
Diabetes Education Program, Clinical Nutrition Department
Putnam Hospital Center, Carmel, New York 10512
Indrani Dhar is a Registered Dietitian, Certified Diabetes Educator and outpatient nutritional counselor, currently leading the Clinical Nutrition Department and Diabetes Education Program at Putnam Hospital Center in New York. She received her Bachelor of Science in Food & Nutrition from Rutgers University, and earned her Masters degree in Nutrition from New York University. Ms. Dhar regularly contributes her expertise to support groups for individuals dealing with ALS, Parkinson's disease and Diabetes.
She has also been invited to speak at various events in New York, New Jersey and Connecticut promoting the importance healthy eating and an active lifestyle. Having been in the field of community and healthcare Nutrition for over three decades, her standing message is a simple one: no one should be on a "diet" but instead eat real food, in the right amounts, and maintain an active lifestyle, while being centered and mindful of priorities.
Kallol Chattopadhay, M.S.Pharm.
School of Pharmacy, Chapman University
Rinker Health Science Campus, Irvine, CA 92618
Kallol Chattopadhyay (“Kal Chatto”) is a Bio-Pharma executive with 30 years of professional experience in leading US and global Bio-Pharmaceuticals companies. Kal's core competencies include:P&L management, M&A integrations, Investor Relations, Clinical Research & Development Strategy, Medical Education and broad bio therapeutic commercialization expertise.
Kal co-founded successful Clinical Research Organizations namely Ecron Acunova and help taking EA to top 3 CRO amongst 100 CRO's in India. Kal served Amgen Inc. (1988 - 2005) in several leadership capacities. He was recruited from Glaxo Pharmaceuticals as one of the first nine Amgen founding leaders to commercialize multiple blockbuster biotech products and directly building & shaping the paramount success of Amgen!
Kal Chatto has served on boards of leading professional organizations and pharmacy schools (e.g.,The FIP Foundation, ACCP Research Institute, USC School of Pharmacy, University of Wisconsin, University of Tennessee, University of Arizona, Chapman University, etc.). He has served as a Visiting Professor to the College of Pharmacy, Manipal University from 2013 – 2017. Kal has been invited to speak at numerous Bio-Pharma meetings and symposia such as BIO, APhA, FIP, IPSF, EPSA, Bio-Asia, etc. He was selected as one of the top executives to serve USA Presidential Round-table (2001-2007). Kal was the first recipient of FIP 2005 Distinguished Service Award, one of the highest honors given by the Federation Of International Pharmaceutical Sciences and the prestigious ACCP 2004 Award. Kallol will be recognized in the House of Lords, London with the “Pravasi Rattan Award-2018”,one of the highest honor given to NRI to recognize outstanding services, achievements and contributions for keeping the “Flag of India High”.
Kallol Chattopadhyay received his B.Pharm from I.I.T, Banaras Hindu University, India and M.S. in Pharmacy Administration from the Long Island University, New York. He has also completed Executive Management Programs from the Marshall School of Business, USC and the Anderson School of Management, UCLA., Los Angeles, CA.